Decipherbio.com

Decipherbio.com has Server used 35.229.110.62 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2015-02-13 (6 years, 163 days) and hosted in Ann Arbor United States, server ping response time 24 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Decipherbio keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Decipherbio
2 Decipherbio.com/prostate
3 Decipher biosciences
4 Decipher biosciences san diego
5 Decipher biopsy
6 Decipher biotech
7 Decipher biomarker
8 Decipher biosciences ca
9 Decipher biosciences npi

Hosting Provider

Website: Decipherbio.com
Hostname: 62.110.229.35.bc.googleusercontent.com
Country:
Region: MI
City: Ann Arbor
Postal Code: 48104
Latitude: 42.273399353027
Longitude: -83.713302612305
Area Code: 734
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Jslidesfootwear.com (28 seconds ago)

   » Decipherbio.com (0 seconds ago)

   » Artuk.org (18 seconds ago)

   » Sunlinecasters.com (6 seconds ago)

   » Wenigfh.com (9 seconds ago)

   » Plazaford.com (7 seconds ago)

   » 2021guomo.com (3 seconds ago)

   » Thegpcgroup.com (5 seconds ago)

Results For Websites Listing

Found 49 Websites with content related to this domain, It is result after search with search engine

Prostate Treatment Planning Patient Decipher Bio

Decipherbio.com   DA: 15 PA: 10 MOZ Rank: 25

  • Decipher has been validated in 40 studies across 29,876 patients for metastasis, prostate cancer-specific mortality, and overall survival
  • Ordering the Decipher Prostate Test
  • Orders can be placed through the physician portal, via email to [email protected]decipherbio.com, or by fax to 1.858.408.7420.

Learn More About What Decipher Prostate Can Do For You

Info.decipherbio.com   DA: 20 PA: 32 MOZ Rank: 53

Decipher Prostate Biopsy may help determine if you are a suitable candidate for active surveillance, if you need local therapy, or if you need intensified therapy Decipher Prostate RP Brochure Decipher Prostate RP may help determine if you can be safely monitored after prostate surgery or if you need additional treatment What to Expect Brochure

Pay Your Patient Bill

Questdiagnostics.com   DA: 24 PA: 6 MOZ Rank: 32

Conveniently pay your Quest Diagnostics invoice or update your insurance information using our secure online form.

Patient Billing Information BioReference Laboratories

Bioreference.com   DA: 20 PA: 18 MOZ Rank: 41

  • Looking to pay your bill or view your test results? The laboratory is now at your fingertips
  • In a Hurry? Get in and out faster by scheduling an appointment Appointment
  • Out-of-Pocket Cost Estimator.Estimate your out-of-pocket cost with our new tool.

Decipher Biopsy And Decipher RP: Decipher

Pcmarkers.com   DA: 17 PA: 17 MOZ Rank: 38

  • To begin ordering tests in your clinic, please reach out to Decipher Biosciences via email at [email protected]decipherbio.com, or via phone at 1 888.792.1601
  • More videos are available at Decipher's Youtube Page
  • Sample order form for Decipher Biopsy and Decipher RP
  • ConfirmMDx TRF Editable IR-FORM-0055-R05.

Department Of Veterans Affairs Federal Supply Service

Gsaadvantage.gov   DA: 20 PA: 50 MOZ Rank: 75

  • Email Address: [email protected]decipherbio.com 12
  • Testing/specimen pick up/request procedures: Pre-paid FedEx bags are provided within the Decipher sampling kit
  • Following packing and shipping instructions provided in the Decipher kit, place the specimen into the provided FedEx bag and seal shut

Decipher Biosciences (DECI) Company Profile & Overview

Stockanalysis.com   DA: 17 PA: 21 MOZ Rank: 44

  • Decipher Biosciences is a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers
  • Our novel prostate cancer genomic testing products, Decipher Biopsy and Decipher RP, provide valuable information about the underlying biology of a patient’s

VA National Acquisition Center Contract Catalog Search Tool

Vendorportal.ecms.va.gov   DA: 28 PA: 33 MOZ Rank: 68

  • The National Acquisition Center Contract Catalog Search Tool now allows your facility to browse MedSurg and Pharmaceutical products and services available under Federal Supply Service contracts
  • The search tool allows the user to locate items using a variety of search criteria, including item description, special item number (SIN) and contract number.

Decipher Biosciences Company Profile Management And

Datanyze.com   DA: 16 PA: 41 MOZ Rank: 65

Decipher Biosciences Profile and History Decipher Biosciences is a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers.

JazzHR » Job Listings

Decipherbio.applytojob.com   DA: 26 PA: 30 MOZ Rank: 65

  • A “disabled veteran” is one of the following: a veteran of the U.S
  • military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or

Decipher Urologic Cancers

Facebook.com   DA: 16 PA: 25 MOZ Rank: 51

Decipher Urologic Cancers, a part of Veracyte, offers novel prostate cancer genomic tests that provide valuable

Decipher Biosciences VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 81

  • "Decipher Biosciences discovers, develops, and commercializes genomic-based laboratory tests
  • Decipher Biosciences enables physicians to provide personalized medical care for cancer patients.

Decipher Urologic Cancers LinkedIn

Linkedin.com   DA: 16 PA: 33 MOZ Rank: 61

Decipher Urologic Cancers Biotechnology San Diego, California 3,777 followers Decipher, a part of Veracyte, offers genomic tests for urologic cancers.

Decipher Biosciences Company Profile

Craft.co   DA: 8 PA: 21 MOZ Rank: 42

  • Decipher Biosciences has 82 employees across 3 locations and $50.7 m in total funding,
  • See insights on Decipher Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Molecular Characterization Of Residual Bladder Cancer

Pubmed.ncbi.nlm.nih.gov   DA: 23 PA: 10 MOZ Rank: 47

  • 7 Decipher Biosciences Inc., San Diego, CA, USA
  • 8 Department of Urology, University Hospital Bern, Bern, Switzerland
  • 9 Department of Urology, University of Washington, Seattle, WA, USA
  • 10 Department of Urology, UT Southwestern Medical Center, Dallas, TX.

Decipher Urologic Cancers Company Profile: Acquisition

Pitchbook.com   DA: 13 PA: 26 MOZ Rank: 54

  • Decipher Urologic Cancers General Information Description
  • Developer of genomic tests designed to improve cancer patient care and outcomes
  • The company's platform is a clinically annotated genomic expression database for urological cancers, enabling the medical community and cancer patients to optimally access an assessment of tumor aggressiveness based on their unique genomic …

Impact Of Molecular Subtyping And Immune Infiltration On

Pubmed.ncbi.nlm.nih.gov   DA: 23 PA: 10 MOZ Rank: 49

  • Electronic address: [email protected]decipherbio.com
  • PMID: 32165065 DOI: 10.1016/j.eururo.2020.02.028 Abstract Background: The PURE-01 study (NCT02736266) evaluated the use of pembrolizumab before radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC)

Decipher Test Clinically Validated As A Predictor Of

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 85

Decipher Prostate (Decipher Prostate Biopsy and Decipher Prostate RP) is a 22-gene, microarray-based genomic test intended to help inform treatment decisions for men with localized prostate cancer

Presentations For The Medicare Clinical Laboratory Fee

Cms.gov   DA: 11 PA: 50 MOZ Rank: 79

  • Federal government websites often end in .gov or .mil
  • Before sharing sensitive information, make sure you’re on a federal government site.

Decipher Biosciences Achieves Major Medicare Milestone For

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 87

Decipher Biosciences also has effective Medicare coverage for use of Decipher Prostate in men with very low and low risk prostate cancer as well as men with adverse pathological findings after

IPO: Decipher Biosciences

Renaissancecapital.com   DA: 26 PA: 38 MOZ Rank: 84

  • Decipher Biosciences Acquired, Nasdaq: DECI
  • Provides genomic testing products for urologic oncology
  • We are a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers
  • Our novel prostate cancer genomic testing products, Decipher Biopsy and

Decipher Identifies A Molecular Subtype Most Likely To

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 89

/PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers,

Doug Dolginow, Genomedx Biosciences Inc: Profile And

Bloomberg.com   DA: 17 PA: 23 MOZ Rank: 62

  • researches biomedical testing solutions
  • The Company discovers, develops, and commercializes genomic-based laboratory tests
  • Decipher Biosciences enables physicians to

EviCore Clinical Guidelines Incorporate Decipher Prostate

Biospace.com   DA: 16 PA: 50 MOZ Rank: 89

  • Decipher Prostate is the first and only genomic test recognized by eviCore for the management of prostate cancer patients after surgery
  • 7, 2020 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers, today announced that eviCore Healthcare (eviCore), a …

Virtual Exhibit Hall Booth-UCLA-Decipher

Cmeinfo.com   DA: 15 PA: 42 MOZ Rank: 81

  • Decipher Biosciences is reimagining the use of genomic information to transform and improve cancer patient care
  • Decipher Prostate is a 22-gene, microarray-based genomic test intended help inform treatment decisions for men with localized prostate cancer at initial diagnosis (Decipher Prostate Biopsy) and after surgical removal of the prostate (Decipher Prostate RP).

Company Details :: Medtech Insight

Medtech.pharmaintelligence.informa.com   DA: 38 PA: 15 MOZ Rank: 78

  • This copy is for your personal, non-commercial use
  • For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Alexandra Klinger's Email & Phone DecipherBio

Contactout.com   DA: 14 PA: 26 MOZ Rank: 66

Founder @ DecipherBio Postdoctoral Fellow @ University of Pennsylvania Postdoctoral Fellow @ University of Pennsylvania Education: About: A UVA and Washington University School of Medicine trained biophysicist with over ten years of academic and pharmaceutical research experience spanning theoretical and applied biothermodynamics to HTS and

Elai Davicioni, Genomedx Biosciences Inc: Profile And

Bloomberg.com   DA: 17 PA: 24 MOZ Rank: 68

  • Elai Davicioni is Former Chief Scientific Officer/Founder at Genomedx Biosciences Inc
  • See Elai Davicioni's compensation, career history, education, & memberships.

Decipher Urologic Cancers LinkedIn

Ca.linkedin.com   DA: 15 PA: 33 MOZ Rank: 76

  • https://decipherbio.com 21 Likes Like Comment Share
  • Decipher Urologic Cancers 3,734 followers
  • Report this post We're excited to officially be part of the Veracyte, Inc
  • Together we will deliver comprehensive genomic cancer testing to physicians and patients and expand our reach into 7 of the top 10 cancers in the U.S

Decipher Biosciences Achieves Major Medicare Milestone For

Preipopharma.com   DA: 20 PA: 50 MOZ Rank: 99

  • 3, 2019 /PRNewswire/ -- Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), issued a final local coverage determination (LCD) for use of Decipher® Prostate Biopsy in men diagnosed with favorable and unfavorable intermediate-risk prostate cancer.

NCCN Guidelines Designate Decipher Prostate As

Biospace.com   DA: 16 PA: 50 MOZ Rank: 96

  • The first and only genomic test to achieve "Recommended" status for the management of prostate cancer patients
  • SAN DIEGO, March 24, 2020 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers, today announced that the Decipher ® Prostate RP genomic test is now …

Recently Analyzed Sites

Jslidesfootwear.com (29 seconds ago)

Decipherbio.com (1 seconds ago)

Artuk.org (19 seconds ago)

Studyinassam.com (0 seconds ago)

Sunlinecasters.com (7 seconds ago)

Wenigfh.com (10 seconds ago)

Plazaford.com (8 seconds ago)

2021guomo.com (4 seconds ago)

Thegpcgroup.com (6 seconds ago)

Oregonflutestore.com (1 seconds ago)

Fordupfits.com (5 seconds ago)

Trans-medic.com (5 seconds ago)

Nen-ei.com (8 seconds ago)

Gainblox.com (4 seconds ago)

Cindypritzker.com (1 seconds ago)

Diyilunwen.com (8 seconds ago)

Celllinedevelopment.com (0 seconds ago)